592
M. Molteni et al. / Tetrahedron Letters 48 (2007) 589–593
Endopeptidase 24.11 (NEP). The assay was carried out
by a method based on the procedure reported by Floren-
tin et al.14 All the w[NHCH(CF3)]-retro-thiorphan dia-
stereomers 1 showed IC50 values several orders of
magnitude higher than thiorphan, with Ki values over
4 M (for reference compound: IC50 = 5.06 nM, Ki =
2.53 nM). Moreover, the comparison of the results
obtained for the new w[NHCH(CF3)] isosteres 1 with
the data reported for (R) and (S)-retro-thiorphan
(Ki = 2.3 nM and 210 nM, respectively)15 confirmed
the loss of the NEP inhibition capacity. This dramatic
drop of inhibitory activity might be due to the fact that
the retropeptidic carbonyl group of retro-thiorphan is
known to be involved in critical interactions with the
active site of NEP as hydrogen bond acceptor.16 There-
fore its replacement with the trifluoroethylamine func-
tion, which is a very weak hydrogen bond acceptor,17
could be the underlying reason for the loss of potency.
This observation suggests important considerations for
a successful use of the trifluoroethylamine function as
a peptide/retropeptide bond mimic (Fig. 2). (1) The tri-
fluoromethyl group, contrarily to the carbonyl oxygen,
is a weak hydrogen-bond acceptor.17 The trifluoroethyl-
amine function can be therefore an effective peptide
bond replacement only if the carbonyl group of the ori-
ginal ligand’s amide/peptide-bond is not involved in
essential hydrogen-bonding with the receptor. (2) The
NH of the trifluoroethylamine unit is a good hydro-
gen-bond donor, due to the strong electronwithdrawing
effect exerted by the CF3 group, and could be always
considered a good mimic of a peptidic NH. (3) The
sp3 N atom of the trifluoroethylamine function is a
bad hydrogen bond acceptor and has very little Lewis
basicity, in close analogy with the peptide bond.4a
w[NHCH(CF3)] analogue 1 of retro-thiorphan. An
alternative route to 1, obtained in this case as an epi-
meric mixture at the CF3-substituted stereocentre, has
been developed as well from ethyl trifluorocrotonate.
Unfortunately, all the diastereomers of 1 showed low
inhibitory activity of NEP compared with the reference
compounds thiorphan and retro-thiorphan.
Acknowledgments
We thank MIUR (Cofin 2004 Project ‘Polipeptidi Bioat-
tivi e Nanostrutturati, and Project ‘Nuovi peptidomime-
`
tici ad attivita analgesica’, protocol No. 13378, 24/12/
2003), Politecnico di Milano, and C.N.R. for economic
support.
References and notes
1. (a) Zanda, M. New J. Chem. 2004, 28, 1401–1411; (b)
´
Begue, J.-P.; Bonnet-Delpon, D.; Crousse, B.; Legros, J.
Chem. Soc. Rev. 2005, 34, 562–572; (c) Gong, Y. F.; Kato,
K. Curr. Org. Chem. 2005, 8, 1659–1675.
´
2. Sani, M.; Molteni, M.; Bruche, L.; Volonterio, A.; Zanda,
M. In Fluorine-Containing Synthons; Soloshonok, V. A.,
Ed.; ACS Publications Division and Oxford University
Press: Washington, DC, 2005; pp 572–592.
3. (a) Volonterio, A.; Bravo, P.; Zanda, M. Org. Lett. 2000,
2, 1827–1830; (b) Volonterio, A.; Bellosta, S.; Bravin, F.;
´
Bellucci, M. C.; Bruche, L.; Colombo, G.; Malpezzi, L.;
Mazzini, S.; Meille, S. V.; Meli, M.; Ramirez de Arellano,
C.; Zanda, M. Chem. Eur. J. 2003, 9, 4510–4522; (c)
Molteni, M.; Volonterio, A.; Zanda, M. Org. Lett. 2003, 5,
3887–3890.
4. (a) Black, W. C.; Bayly, C. I.; Davis, D. E.; Desmarais, S.;
In summary, we have described the aza-Michael addi-
tion of amines and b-amino-alcohols to the chiral N-tri-
fluorocrotonoyl-oxazolidin-2-one 3. The reactions occur
in good to excellent yields, but low stereocontrol. One of
the aza-Michael adducts (5f) was used as the starting
material for the synthesis of the stereopure
´
´
Falgueyret, J.-P.; Leger, S.; Li, C. S.; Masse, F.; McKay,
D. J.; Palmer, J. T.; Percival, M. D.; Robichaud, J.; Tsou,
N.; Zamboni, R. Bioorg. Med. Chem. Lett. 2005, 15, 4741–
4744; (b) Li, C. S.; Deschenes, D.; Desmarais, S.;
´
Falgueyret, J.-P.; Gauthier, J. Y.; Kimmel, D. B.; Leger,
´
S.; Masse, F.; McGrath, M. E.; McKay, D. J.; Percival,
´
M. D.; Riendeau, D.; Rodan, S. B.; Therien, M.; Truong,
V.-L.; Wesolowski, G.; Zamboni, R.; Black, W. C. Bioorg.
Med. Chem. Lett. 2006, 16, 1985–1989.
5. Link, J. O.; Zipfel, S. Curr. Opin. Drug Discovery Dev.
2006, 9, 471–482.
Receptor
H
Peptide bond
O
6. (a) Fletcher, M. D.; Campbell, M. M. Chem. Rev. 1998,
98, 763–795; (b) Goodman, M.; Chorev, M. Acc. Chem.
Res. 1979, 12, 1–7.
N
H
7. Roques, B. P.; Lucas-Soroca, E.; Chaillet, P.; Costentin,
X
Receptor
C=O good H-bond acceptor
N bad H-bond acceptor
NH good H-bond donor
´
J.; Fournie-Zaluski, M. C. Proc. Natl. Acad. Sci. U.S.A.
1983, 80, 3178–3182.
8. Synthesis of 5a. TEA (2 equiv) and AcOH (2 equiv) were
added at rt to a solution of 3 (1 equiv) in DCM (0.2 M
solution). After 5 min 4a was added at rt and the reaction
monitored by TLC. The mixture was diluted with 1 N
aqueous HCl solution, extracted with DCM, the collected
organic layers dried (Na2SO4), filtered, concentrated under
reduced pressure, and the crude purified by flash chroma-
tography. 5a (one diastereoisomer): 1H (400 MHz,
CDCl3): d 7.29 (m, 5H), 4.39 (m, 1H), 4.21 (m, 2H), 4.03
(d, J = 13.2 Hz, 1H), 3.85 (d, J = 13.2 Hz, 1H), 3.79 (m,
1H), 3.43 (dd, J = 16.2 and 9.4 Hz, 1H), 3.11 (dd, J = 16.2
and 4.1 Hz, 1H), 2.39 (m, 1H), 0.92 (d, J = 7.1 Hz, 3H),
0.84 (d, J = 6.8 Hz, 3H).
Receptor
H
Trifluoroethylamine
function
CF3
N
H
X
Receptor
CH-CF3 bad H-bond acceptor
N bad H-bond acceptor
NH good H-bond donor
X = O, N, etc.
Figure 2. Comparison between the peptide (amide) bond and the
trifluoroethylamine function.